½ÃÀ庸°í¼­
»óǰÄÚµå
1589160

Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀå : Á¦Ç° À¯Çü, °Ëü À¯Çü, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Coronavirus Test Kits Market by Product Type (Immunoassay Test Strips or Cassettes, RT-PCR Assay Kits, Self-testing Kits), Specimen Type (Nasal Swab, Nasopharyngeal Swab, Oropharyngeal Swab), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 197 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀåÀº 2023³â¿¡ 191¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 222¾ï 4,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 14.68%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 499¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀåÀº SARS-CoV-2ÀÇ Á¸À縦 °¨ÁöÇÏ´Â µ¥ »ç¿ëµÇ´Â Áø´Ü µµ±¸ÀÇ »ý»ê ¹× ¹èÆ÷·Î Á¤ÀǵǸç, °øÁß º¸°Ç¿¡ ´ëÇÑ Àû½Ã ´ëÀÀÀ» ÃËÁøÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °Ë»ç ŰƮ´Â °¨¿°ÀÚ¸¦ ½Äº°ÇÏ¿© Äڷγª19ÀÇ È®»êÀ» °ü¸®Çϰí Ä¡·á °áÁ¤°ú °Ý¸® Á¶Ä¡¸¦ ¾È³»ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ¿ëµµ¿¡´Â ÇÙ»ê °ËÃâÀ» À§ÇÑ RT-PCR °Ë»ç, ¹Î°¨µµ´Â ³·Áö¸¸ ½Å¼ÓÇÑ Áø´ÜÀ» À§ÇÑ Ç׿ø °Ë»ç, °ú°Å °¨¿°À» Æò°¡Çϱâ À§ÇÑ Ç×ü °Ë»ç µîÀÌ ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ëó´Â º´¿ø, Ŭ¸®´Ð, Áø´Ü ½ÇÇè½Ç, °¡Á¤ µî ´Ù¾çÇϸç, °¢±â ´Ù¸¥ ¿ä±¸ »çÇ×°ú ¿ä±¸ »çÇ×ÀÌ Å×½ºÆ® ŰƮÀÇ ¼³°è ¹× À¯Åë¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº Àü ¼¼°èÀûÀÎ ÆÒµ¥¹Í ´ëºñ¿¡ ´ëÇÑ °ü½É, ÀÇ·áºñ ÁöÃâ Áõ°¡, ÇöÀåÁø´Ü(POC) ¼Ö·ç¼ÇÀ» Æ÷ÇÔÇÑ °Ë»ç ±â¼úÀÇ ¹ßÀü µî ¿©·¯ ¿äÀÎÀÌ ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ´Â ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ Àúºñ¿ëÀ¸·Î ½Å¼ÓÇÑ °Ë»ç È®´ë, ¸ð´ÏÅ͸µ ¹× µ¥ÀÌÅÍ °ü¸®¸¦ À§ÇÑ µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ ÅëÇÕ¿¡ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »õ·Î¿î º¯Á¾¿¡ ´ëÇÑ ½ÃÀåÀÇ ¹ÎøÇÑ ´ëÀÀµµ ¼ºÀå °¡´É¼ºÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. ±×·¯³ª Àü¿°º´ÀÌ ÀýÁ¤¿¡ ´ÞÇÑ ÈÄ ¼ö¿ä º¯µ¿, ±ÔÁ¦Àû Àå¾Ö¹°, ³ôÀº Á¤È®µµ¿Í ³·Àº À§¾ç¼º·üÀÇ °Ë»ç °á°úÀÇ Çʿ伺 µîÀÇ °úÁ¦°¡ ³²¾Æ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °ø±Þ¸ÁÀÇ Áö¼Ó°¡´É¼º°ú ¼¼°è ¹«¿ª¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁöÁ¤ÇÐÀû ±äÀåµµ Àå¾Ö¹°ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀÇ ±âȸ·Î´Â ¿©·¯ º´¿øÃ¼¸¦ µ¿½Ã¿¡ Áø´ÜÇÒ ¼ö ÀÖ´Â ´Ù±â´É ŰƮ °³¹ß, ´õ ºü¸¥ °á°ú¸¦ ¾ò±â À§ÇÑ ¹ÙÀÌ¿À¼¾¼­ °­È­, ½Ç½Ã°£ µ¥ÀÌÅÍ ÃßÀûÀ» À§ÇÑ ¸ð¹ÙÀÏ Çコ ¿ëµµÀÇ °³¼± µîÀÌ ÀÖ½À´Ï´Ù. ½ÃÀåÀº °æÀïÀÌ Ä¡¿­Çϸç, »õ·Î¿î º¯Á¾°ú °øÁߺ¸°Ç À§±â µî »õ·Î¿î µµÀü¿¡ ¾Õ¼­ ³ª°¡±â À§Çؼ­´Â Áö¼ÓÀûÀÎ ¿¬±¸°³¹ßÀÌ ÇʼöÀûÀÔ´Ï´Ù. ¼º°øÀ» ¿øÇÏ´Â ±â¾÷Àº Àü·«Àû ÆÄÆ®³Ê½ÊÀ» Áß½ÃÇϰí, ±ÔÁ¦ ¾÷µ¥ÀÌÆ®¿¡ ½Å¼ÓÇÏ°Ô ´ëÀÀÇϰí, °ø±Þ¸ÁÀÌ ¼¼°è È¥¶õÀ» °ßµô ¼ö ÀÖµµ·Ï ÇØ¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ, º¸¿ÏÀûÀÎ °Ç°­ Áø´Ü ÀǾàǰÀ¸·ÎÀÇ ÁøÃâÀº ±âÁ¸ ±â¼ú °­Á¡À» Ȱ¿ëÇÏ¿© Æ÷Æ®Æú¸®¿À¸¦ ´Ù¾çÈ­ÇÔÀ¸·Î½á »ç¾÷ ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 191¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 222¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 499¾ï 7,000¸¸ ´Þ·¯
CAGR(%) 14.68%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ¸·Î º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Äڷγª19 ÆÒµ¥¹ÍÀÇ Àü ¼¼°èÀû È®»ê
    • NAAT ¹× RT-PCR °Ë»çÀÇ ´ëÆøÀûÀÎ ´ëÁßÈ­
    • Äڷγª19 ÁõÈıºÀ» °¨ÁöÇϱâ À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í ÀÎ½Ä Á¦°í Ä·ÆäÀÎ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °Ë»ç ŰƮ À̿뿡 ´ëÇÑ ÀÎ½Ä ºÎÁ·°ú ÀúÇ×°¨
  • ½ÃÀå ±âȸ
    • »õ·Î¿î Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÂÀÎ ¹× °³¹ß ±ÞÁõ
    • ½Å¼Ó Ç׿ø °ËÃâ °Ë»ç(RADT) ¹× ÇöÀå Áø·á(POC) °Ë»ç È®»ê
  • ½ÃÀå °úÁ¦
    • °Ë»ç ŰƮÀÇ ±â¼úÀû ÇѰ迡 ´ëÇÑ ¿ì·Á

Portre's Five Forces: Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀå¿¡ ´ëÇÑ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Äڷγª¹ÙÀÌ·¯½º Å×½ºÆ® ŰƮ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Äڷγª¹ÙÀÌ·¯½º Å×½ºÆ® ŰƮ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º Äڷγª¹ÙÀÌ·¯½º Å×½ºÆ® ŰƮ ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Äڷγª¹ÙÀÌ·¯½º Å×½ºÆ® ŰƮ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀå : Á¦Ç° À¯Çüº°

  • ¸é¿ªÃøÁ¤ Å×½ºÆ® ½ºÆ®¸³ ¶Ç´Â Ä«¼¼Æ®
    • Ç×ü
    • Ç׿ø
  • RT-PCR ¾î¼¼ÀÌ Å°Æ®
  • ÀÚ°¡ °Ë»ç ŰƮ

Á¦7Àå Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀå : Ç¥º» À¯Çüº°

  • ºñ°­ ½º¿Ò
  • ºñÀεΠ½º¿Ò
  • ±¸°­ ÀεΠ½º¿Ò
  • °¡·£

Á¦8Àå Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • Ŭ¸®´Ð
  • Áø´Ü¼¾ÅÍ
  • ȨÄɾî
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Äڷγª¹ÙÀÌ·¯½º °Ë»ç ŰƮ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • 1DROP Diagnostics
  • Abbott Laboratories
  • ADT Biotech Sdn Bhd
  • Aldatu Biosciences
  • altona Diagnostics GmbH
  • Avellino Lab USA, Inc.
  • bioMerieux SA
  • Co-Diagnostics, Inc.
  • Curetis GmbH
  • Danaher Corporations
  • F. Hoffmann-La Roche AG
  • GenMark Diagnostics, Inc.
  • Hologic, Inc.
  • Laboratory Corporation of America Holdings
  • Luminex Corporation
  • Mylab Discovery Solutions Pvt. Ltd.
  • Perkin Elmer, Inc.
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • SD Biosensor, Inc.
  • Seegene, Inc.
  • Shenzhen Bioeasy Biotechnology Co., Ltd.
  • Siemens Healthineers AG
  • SolGent Co.,Ltd.
  • Thermo Fisher Scientific Inc.
LSH

The Coronavirus Test Kits Market was valued at USD 19.14 billion in 2023, expected to reach USD 22.24 billion in 2024, and is projected to grow at a CAGR of 14.68%, to USD 49.97 billion by 2030.

The coronavirus test kits market is defined by the production and deployment of diagnostic tools utilized to detect the presence of SARS-CoV-2, facilitating timely public health responses. These test kits are essential due to their critical role in managing the spread of COVID-19 by identifying infected individuals, thereby guiding treatment decisions and quarantine measures. Key applications include RT-PCR tests for nucleic acid detection, antigen tests for quicker but less sensitive diagnosis, and antibody tests to assess previous infections. The end-use scope spans hospitals, clinics, diagnostic laboratories, and home settings, each having unique requirements and demands influencing test kit design and distribution. Market growth is driven by factors such as the global emphasis on pandemic preparedness, increased healthcare expenditure, and technological advancements in testing, including point-of-care (POC) solutions. Emerging opportunities lie in expanding low-cost, rapid testing in underserved regions, and integrating digital health solutions for monitoring and data management. The market's agility in responding to new variants also presents growth prospects. However, challenges include fluctuating demand post-pandemic peaks, regulatory hurdles, and the need for high accuracy and low false-positive rates in test results. There are also obstacles in supply chain sustainability and geopolitical tensions affecting global trade. Opportunities for innovation include the development of multi-functional kits that simultaneously diagnose multiple pathogens, enhanced biosensors for faster results, and improved mobile health applications for real-time data tracking. The market is highly competitive, with continuous R&D essential for staying ahead of new challenges such as emerging variants or public health crises. Companies looking to thrive should focus on strategic partnerships, adapting to regulatory updates swiftly, and ensuring their supply chain can withstand global disruptions. Expansion into complementary health diagnostics could also augment business growth, leveraging existing technological strengths for diversified portfolios.

KEY MARKET STATISTICS
Base Year [2023] USD 19.14 billion
Estimated Year [2024] USD 22.24 billion
Forecast Year [2030] USD 49.97 billion
CAGR (%) 14.68%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Coronavirus Test Kits Market

The Coronavirus Test Kits Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of COVID-19 pandemic all over the world
    • Significant adoption of NAAT and RT-PCR tests
    • Rising government initiatives and awareness campaigns for detection of COVID-19 syndrome
  • Market Restraints
    • Limited awareness and resistance in utilizing test kits
  • Market Opportunities
    • Surge in approvals and developments of new coronavirus test kits
    • Proliferation of rapid antigen detection tests (RADTs) and point-of-care (POC) testing
  • Market Challenges
    • Concerns regarding technical limitations of test kits

Porter's Five Forces: A Strategic Tool for Navigating the Coronavirus Test Kits Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Coronavirus Test Kits Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Coronavirus Test Kits Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Coronavirus Test Kits Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Coronavirus Test Kits Market

A detailed market share analysis in the Coronavirus Test Kits Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Coronavirus Test Kits Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Coronavirus Test Kits Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Coronavirus Test Kits Market

A strategic analysis of the Coronavirus Test Kits Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Coronavirus Test Kits Market, highlighting leading vendors and their innovative profiles. These include 1DROP Diagnostics, Abbott Laboratories, ADT Biotech Sdn Bhd, Aldatu Biosciences, altona Diagnostics GmbH, Avellino Lab USA, Inc., bioMerieux SA, Co-Diagnostics, Inc., Curetis GmbH, Danaher Corporations, F. Hoffmann-La Roche AG, GenMark Diagnostics, Inc., Hologic, Inc., Laboratory Corporation of America Holdings, Luminex Corporation, Mylab Discovery Solutions Pvt. Ltd., Perkin Elmer, Inc., Quidel Corporation, Randox Laboratories Ltd., SD Biosensor, Inc., Seegene, Inc., Shenzhen Bioeasy Biotechnology Co., Ltd., Siemens Healthineers AG, SolGent Co.,Ltd., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Coronavirus Test Kits Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Immunoassay Test Strips or Cassettes, RT-PCR Assay Kits, and Self-testing Kits. The Immunoassay Test Strips or Cassettes is further studied across Antibody and Antigen.
  • Based on Specimen Type, market is studied across Nasal Swab, Nasopharyngeal Swab, Oropharyngeal Swab, and Sputum.
  • Based on End-User, market is studied across Clinics, Diagnostic Centers, Homecare, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of COVID-19 pandemic all over the world
      • 5.1.1.2. Significant adoption of NAAT and RT-PCR tests
      • 5.1.1.3. Rising government initiatives and awareness campaigns for detection of COVID-19 syndrome
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and resistance in utilizing test kits
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in approvals and developments of new coronavirus test kits
      • 5.1.3.2. Proliferation of rapid antigen detection tests (RADTs) and point-of-care (POC) testing
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding technical limitations of test kits
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Coronavirus Test Kits Market, by Product Type

  • 6.1. Introduction
  • 6.2. Immunoassay Test Strips or Cassettes
    • 6.2.1. Antibody
    • 6.2.2. Antigen
  • 6.3. RT-PCR Assay Kits
  • 6.4. Self-testing Kits

7. Coronavirus Test Kits Market, by Specimen Type

  • 7.1. Introduction
  • 7.2. Nasal Swab
  • 7.3. Nasopharyngeal Swab
  • 7.4. Oropharyngeal Swab
  • 7.5. Sputum

8. Coronavirus Test Kits Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Diagnostic Centers
  • 8.4. Homecare
  • 8.5. Hospitals

9. Americas Coronavirus Test Kits Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Coronavirus Test Kits Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Coronavirus Test Kits Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 1DROP Diagnostics
  • 2. Abbott Laboratories
  • 3. ADT Biotech Sdn Bhd
  • 4. Aldatu Biosciences
  • 5. altona Diagnostics GmbH
  • 6. Avellino Lab USA, Inc.
  • 7. bioMerieux SA
  • 8. Co-Diagnostics, Inc.
  • 9. Curetis GmbH
  • 10. Danaher Corporations
  • 11. F. Hoffmann-La Roche AG
  • 12. GenMark Diagnostics, Inc.
  • 13. Hologic, Inc.
  • 14. Laboratory Corporation of America Holdings
  • 15. Luminex Corporation
  • 16. Mylab Discovery Solutions Pvt. Ltd.
  • 17. Perkin Elmer, Inc.
  • 18. Quidel Corporation
  • 19. Randox Laboratories Ltd.
  • 20. SD Biosensor, Inc.
  • 21. Seegene, Inc.
  • 22. Shenzhen Bioeasy Biotechnology Co., Ltd.
  • 23. Siemens Healthineers AG
  • 24. SolGent Co.,Ltd.
  • 25. Thermo Fisher Scientific Inc.
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦